Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa Dose-Finding for Monofollicular Ovulation in WHO Group II Anovulatory Infertility
NCT00702585Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2001
- Primary completion
- Oct 2002
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
01
Overview
Phase 2, randomised, double-blind trial of corifollitropin alfa (5 arms), sponsored by Organon & Co. Primary endpoint: Participant Ovulation Rate in Monofollicular Cycles. Started Aug 2001; status: completed.
02
Drugs
corifollitropin alfa
Beyond the preview
Go deeper on NCT00702585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702585.